tradingkey.logo


tradingkey.logo


Anbio Biotechnology

NNNN

詳现チャヌトを衚瀺
25.650USD
+1.590+6.61%
終倀 02/06, 16:00ET15分遅れの株䟡
1.13B時䟡総額
416.53盎近12ヶ月PER


Anbio Biotechnology

25.650
+1.590+6.61%
Intraday
1m
30m
1h
D
W
M
D

本日

+6.61%

5日間

+17.07%

1ヶ月

-20.07%

6ヶ月

-42.42%

幎初来

-14.70%

1幎間

0.00%

詳现チャヌトを衚瀺

TradingKey 株匏スコア

デヌタが䞍十分なため、株匏スコアは利甚できたせん。

Anbio Biotechnology ニュヌス

最新情報をお埅ちください...

財務指暙

EPS

䌚瀟から関連デヌタがただ開瀺されおいたせん。

総売䞊高

䌚瀟から関連デヌタがただ開瀺されおいたせん。

Anbio Biotechnologyの䌁業情報

Anbio Biotechnology is a Germany-based medical device company. The Company is engaged in the development of medical technology and the provision of in vitro diagnostics (IVD) products. Its products offer solutions for over the counter (OTC) use, point-of-care (POCT) settings, and laboratory applications, ensuring that both healthcare providers and patients have access to reliable and efficient diagnostic tools in any setting. Its IVD products detect a wide range of biomarkers across critical medical fields, including infectious diseases, cancer, cardiovascular diseases, inflammation, drug abuse, endocrine disorders, renal disease, pharmacogenomics, and diabetes. Some of its IVD platforms: Chemiluminescence Immunoassay (ChLIA), Lateral Flow Immunoassay (LFIA), Fluorescent Immunoassay (FIA), Polymerase Chain Reaction (PCR) and Loop-mediated Isothermal Amplification (LAMP).
䌁業コヌドNNNN
䌁業名Anbio Biotechnology
最高経営責任者「CEO」Lau (Michael)
りェブサむトhttps://anbiobiotechnology.com/
KeyAI
î™